Effect of human rotavirus vaccine on severe diarrhea in African infants.
暂无分享,去创建一个
S. Madhi | K. Neuzil | B. Ngwira | B. Cheuvart | N. Cunliffe | J. C. Victor | P. Gillard | C. Louw | D. Steele | H. Han | M. Kirsten | D. Witte | K. Neuzil | Duncan Steele | Cheryl Louw | Paul H Gillard | Brigitte B Cheuvart
[1] M. Molyneux,et al. Epidemiology of rotavirus infection in children in Blantyre, Malawi, 1997-2007. , 2010, The Journal of infectious diseases.
[2] C. Sanderson,et al. Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data , 2009, The Lancet.
[3] R. Ward,et al. Live Attenuated Human Rotavirus Vaccine, RIX4414, Provides Clinical Protection in Infants Against Rotavirus Strains With and Without Shared G and P Genotypes: Integrated Analysis of Randomized Controlled Trials , 2009, The Pediatric infectious disease journal.
[4] D. Sack,et al. Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. , 2009, Vaccine.
[5] J. Dewar,et al. The detection and molecular characterization of human G12 genotypes in South Africa , 2009, Journal of medical virology.
[6] B. Ngwira,et al. Serotype G12 Rotaviruses, Lilongwe, Malawi , 2009, Emerging infectious diseases.
[7] D. M. Rivera-Medina,et al. Oral Human Rotavirus Vaccine RIX4414(Rotarix™) Co-administered with Routine EPI Vaccinations Including Oral Polio Vaccine(OPV) Is Highly Efficacious in Latin-America , 2008 .
[8] D. Anh,et al. Immunogenicity, Reactogenicity and Safety of the Oral Live Attenuated Human Rotavirus Vaccine RIX4414(Rotarix™) Oral Suspension (Liquid Formulation) in Vietnamese Infants , 2008 .
[9] T. Vesikari,et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study , 2007, The Lancet.
[10] C. Oliveira,et al. Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants. , 2007, Jornal de pediatria.
[11] M. O’Ryan. Rotarix™ (RIX4414): an oral human rotavirus vaccine , 2007, Expert review of vaccines.
[12] J. Heyse,et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. , 2006, The New England journal of medicine.
[13] T. Vesikari,et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. , 2006, The New England journal of medicine.
[14] R. Glass,et al. Rotavirus vaccines: targeting the developing world. , 2005, The Journal of infectious diseases.
[15] Roger I Glass,et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. , 2005, The Journal of infectious diseases.
[16] A. Steele,et al. Rotavirus strains circulating in Africa during 1996-1999: emergence of G9 strains and P[6] strains. , 2003, Vaccine.
[17] J. Alexander,et al. Anticipating rotavirus vaccines: epidemiology and surveillance of rotavirus in South Africa. , 2003, Vaccine.
[18] B. Schwartz,et al. Intussusception among infants given an oral rotavirus vaccine. , 2001, The New England journal of medicine.
[19] X. Pang,et al. Rotaviruses detected by reverse transcription polymerase chain reaction in acute gastroenteritis during a trial of rhesus-human reassortant rotavirus tetravalent vaccine: implications for vaccine efficacy analysis. , 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[20] R. Glass,et al. Rotavirus infection in infants as protection against subsequent infections. , 1996, The New England journal of medicine.
[21] Suharyono,et al. Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children , 1992, The Lancet.
[22] S. Hoffman,et al. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine , 1991, The Lancet.
[23] K. Chopra,et al. Antibody response of infants in tropics to five doses of oral polio vaccine. , 1989, Journal of tropical pediatrics.
[24] J. Alexander,et al. Rotavirus-associated gastroenteritis in black infants in South Africa , 1986, Journal of clinical microbiology.
[25] S. P. Deolalkar. Recommendations and Conclusions , 2015 .
[26] Releve Epidemiologique Hebdomadaire. Global networks for surveillance of rotavirus gastroenteritis, 2001-200. , 2008, Releve epidemiologique hebdomadaire.
[27] Meeting of the immunization Strategic Advisory Group of Experts, November 2006--conclusions and recommendations. , 2007, Releve epidemiologique hebdomadaire.
[28] Y. Hoshino,et al. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine , 2005, Reviews in medical virology.
[29] M. Georges-Courbot,et al. Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. , 1991, Research in virology.
[30] T. Vesikari,et al. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. , 1990, Scandinavian journal of infectious diseases.
[31] D. Bernstein,et al. Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. , 1989, The Journal of infectious diseases.